Catalent to manufacture Moderna's personalized cancer vaccine for Ph I/II studies
Catalent has entered into an agreement with Moderna Therapeutics to support the company’s proprietary production process.
Catalent has entered into an agreement with Moderna Therapeutics to support the company’s proprietary production process.
Thermo Fisher Scientific has revealed a preemptive pharmacogenomic risk factor screening tool to help increase drug development outcome efficiency and reduce adverse drug reactions.
The WHO has added side-effect heavy, TB drug ingredient gatifloxacin to its prequalification list to encourage production.
Work has started to expand Agilent’s Fredrick Campus to include a bulk tank farm and manufacturing and lab/office buildings.
Two manufacturing facilities were closed after being hit by Hurricane Matthew earlier this month, according to a Patheon SEC filing.
Premier Research has become the most recent contract research organization (CRO) to receive funding from private equity as the industry looks for "like-minded" partners for the long run.
Certara has expanded its operations as the company prepares to “fully leverage” the value of modeling and simulation in drug development.
CDMO Juniper Pharma Services has added a small-scale roller compactor as the latest investment in its enabling technology offerings.